Royal Bank of Canada’s Picard Medical PMI Stock Holding History

Royal Bank of Canada’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-270	Closed	–	–	7925
2025 Q4	$0	Buy	+270	New	+$1.27K	﹤0.01%	7839

Other funds holding PMI

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada's PMI Position: Q1 2026 in Review

Royal Bank of Canada sold out of Picard Medical (PMI) in Q1 2026, closing a stake of 270 shares.

Royal Bank of Canada first reported a position in PMI in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

Royal Bank of Canada reported no remaining Picard Medical position as of Q1 2026 after selling out during the quarter.
Royal Bank of Canada sold 270 Picard Medical shares in Q1 2026.
Royal Bank of Canada first reported a position in Picard Medical in Q4 2025 and held it in 1 quarter.
Royal Bank of Canada's Picard Medical position peaked at $0 in Q4 2025.
41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.